(ELGX) |
| 0 (0%) 06-12 20:54 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Wed, 26 Jun 2024
Lacrimal gland removal impairs sexual behavior in mice - Frontiers
Tue, 11 May 2021
Endologix launches Alto abdominal stent graft in Canada - MassDevice
Fri, 10 Aug 2018
Here's Why Endologix Plummeted 37% Today - Yahoo Finance
Thu, 12 Oct 2017
ENDOLOGIX, INC. (NASDAQ:ELGX) Files An 8-K Other Events - marketexclusive.com
Wed, 16 Nov 2016
Endologix shares dive on FDA request for more Nellix data - MassDevice
Tue, 27 Oct 2015
Endologix, TriVascular Technologies ink $211m merger - MassDevice
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
